Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,356 | 145 | 95.7% |
| Education | $106.90 | 2 | 4.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $328.04 | 21 | $0 (2024) |
| AIMMUNE THERAPEUTICS, INC. | $240.00 | 1 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $199.80 | 10 | $0 (2024) |
| PFIZER INC. | $194.39 | 13 | $0 (2024) |
| Amgen Inc. | $187.94 | 12 | $0 (2023) |
| Novo Nordisk Inc | $167.49 | 12 | $0 (2024) |
| Lilly USA, LLC | $109.10 | 8 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $107.02 | 6 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $87.10 | 6 | $0 (2022) |
| Merck Sharp & Dohme LLC | $86.53 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $649.63 | 27 | AIMMUNE THERAPEUTICS, INC. ($240.00) |
| 2023 | $505.35 | 32 | ABBVIE INC. ($177.08) |
| 2022 | $452.80 | 28 | PFIZER INC. ($118.59) |
| 2021 | $187.39 | 13 | Amgen Inc. ($44.94) |
| 2020 | $40.62 | 3 | Takeda Pharmaceuticals U.S.A., Inc. ($15.94) |
| 2019 | $174.49 | 14 | Merck Sharp & Dohme Corporation ($33.84) |
| 2018 | $103.71 | 8 | Merck Sharp & Dohme Corporation ($25.89) |
| 2017 | $348.47 | 22 | Boehringer Ingelheim Pharmaceuticals, Inc. ($158.57) |
All Payment Transactions
147 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: DIABETES | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Gastroenterology | ||||||
| 10/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Obesity | ||||||
| 10/22/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.45 | General |
| Category: Cardiovascular | ||||||
| 10/02/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 09/09/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: VACCINE | ||||||
| 08/22/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Diabetes | ||||||
| 08/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Diabetes | ||||||
| 07/22/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $240.00 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 06/24/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Hematology | ||||||
| 06/18/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $15.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Gastroenterology | ||||||
| 05/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: PSYCHIATRY | ||||||
| 05/14/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: PAIN | ||||||
| 04/25/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: VACCINES | ||||||
| 04/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/01/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Biological | ||||||
| 03/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Diabetes | ||||||
| 03/05/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Hematology | ||||||
| 02/28/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Obesity | ||||||
| 01/31/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,189 | 2,352 | $353,264 | $93,430 |
| 2022 | 15 | 1,403 | 2,382 | $369,752 | $93,666 |
| 2021 | 17 | 2,047 | 3,263 | $371,379 | $141,486 |
| 2020 | 20 | 2,378 | 3,512 | $395,682 | $147,174 |
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 383 | 1,321 | $237,780 | $54,740 | 23.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 150 | 154 | $16,940 | $11,060 | 65.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 32 | 32 | $16,800 | $8,731 | 52.0% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 45 | 45 | $13,005 | $5,782 | 44.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 153 | 157 | $5,966 | $4,490 | 75.3% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 45 | 45 | $4,050 | $1,715 | 42.4% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 35 | 37 | $3,330 | $1,410 | 42.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 31 | $4,185 | $1,308 | 31.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 100 | 123 | $5,043 | $1,165 | 23.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 32 | 32 | $1,216 | $886.60 | 72.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 97 | $4,850 | $780.70 | 16.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 11 | 13 | $1,313 | $507.91 | 38.7% |
| 87400 | Detection test by immunoassay technique for influenza virus | Office | 2023 | 11 | 22 | $770.00 | $304.59 | 39.6% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 11 | 11 | $286.00 | $178.20 | 62.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 12 | 12 | $3,420 | $156.81 | 4.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 123 | 123 | $33,825 | $122.15 | 0.4% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 11 | 97 | $485.00 | $91.43 | 18.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 400 | 1,336 | $236,910 | $53,783 | 22.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 157 | 157 | $17,270 | $10,761 | 62.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 29 | 29 | $15,130 | $8,078 | 53.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 165 | 165 | $6,270 | $4,445 | 70.9% |
| 0054A | Adm sarscv2 30mcg trs-sucr b | Office | 2022 | 83 | 83 | $7,470 | $2,945 | 39.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 54 | 73 | $9,103 | $2,775 | 30.5% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 75 | 75 | $6,750 | $2,673 | 39.6% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 64 | 65 | $5,850 | $2,338 | 40.0% |
About Dr. Christopher Heeb, MD
Dr. Christopher Heeb, MD is a Internal Medicine healthcare provider based in Crestview Hills, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1700878162.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Heeb, MD has received a total of $2,462 in payments from pharmaceutical and medical device companies, with $649.63 received in 2024. These payments were reported across 147 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($2,356).
As a Medicare-enrolled provider, Heeb has provided services to 7,017 Medicare beneficiaries, totaling 11,509 services with total Medicare billing of $475,756. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Specialist
- Location Crestview Hills, KY
- Active Since 08/22/2005
- Last Updated 09/10/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1700878162
Products in Payments
- ZENPEP (Drug) $240.00
- VRAYLAR (Drug) $195.41
- ELIQUIS (Drug) $123.55
- XIFAXAN (Drug) $111.67
- JARDIANCE (Drug) $87.11
- UBRELVY (Drug) $85.40
- Otezla (Drug) $74.59
- Ozempic (Drug) $63.54
- JANUVIA (Drug) $59.73
- INJECTAFER (Drug) $56.45
- VYVANSE (Drug) $56.25
- Aimovig (Biological) $56.01
- Wegovy (Drug) $55.38
- PREVNAR 20 (Biological) $41.21
- EMGALITY (Drug) $40.90
- XARELTO (Drug) $38.65
- ANORO (Drug) $37.95
- REXULTI (Drug) $37.37
- GVOKE HYPOPEN (Drug) $35.52
- NURTEC ODT (Drug) $32.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Crestview Hills
Joel Warren, M.d, M.D
Internal Medicine — Payments: $11,688
Ann George, M.d, M.D
Internal Medicine — Payments: $5,753
Kimberly Deringer, Md, MD
Internal Medicine — Payments: $5,093
Steven Campbell, Md, MD
Internal Medicine — Payments: $5,074
Dr. Grant Breazeale, M.d, M.D
Internal Medicine — Payments: $4,591
Dr. Jeevan Joseph, M.d, M.D
Internal Medicine — Payments: $3,588